Skip to content

Clinical trials

Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Country / region: Belgium Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20131
20142
20152
20173
20192
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Amgen2
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
AbbVie1
Charite University, Berlin, Germany1
Children's Oncology Group1
Kiadis Pharma1
Mats Heyman1
Princess Maxima Center for Pediatric Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Leukemia6
Leukemia, Myeloid, Acute5
Lymphoma5
Burkitt Lymphoma4
Leukemia, Biphenotypic, Acute4
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Non-Hodgkin4
Multiple Myeloma4
Recurrence4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.